Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;55(6):529-538.
doi: 10.3961/jpmph.22.128. Epub 2022 Oct 17.

Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older

Youjin Hong  1   2   3 , Sangjun Lee  1   2   4 , Sungji Moon  1   2   5 , Soseul Sung  1   2   4 , Woojin Lim  1   2   4 , Kyungsik Kim  1   2   4 , Seokyung An  1   2   4 , Jeoungbin Choi  1   2   4 , Kwang-Pil Ko  6 , Inah Kim  7 , Jung Eun Lee  8 , Sue K Park  1   2   3
Affiliations

Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older

Youjin Hong et al. J Prev Med Public Health. 2022 Nov.

Abstract

Objectives: This study aimed to identify the current patterns of cancer incidence and estimate the projected cancer incidence and mortality between 2020 and 2035 in Korea.

Methods: Data on cancer incidence cases were extracted from the Korean Statistical Information Service from 2000 to 2017, and data on cancer-related deaths were extracted from the National Cancer Center from 2000 to 2018. Cancer cases and deaths were classified according to the International Classification of Diseases, 10th edition. For the current patterns of cancer incidence, age-standardized incidence rates (ASIRs) and age-standardized mortality rates were investigated using the 2000 mid-year estimated population aged over 20 years and older. A joinpoint regression model was used to determine the 2020 to 2035 trends in cancer.

Results: Overall, cancer cases were predicted to increase from 265 299 in 2020 to 474 085 in 2035 (growth rate: 1.8%). The greatest increase in the ASIR was projected for prostate cancer among male (7.84 vs. 189.53 per 100 000 people) and breast cancer among female (34.17 vs. 238.45 per 100 000 people) from 2000 to 2035. Overall cancer deaths were projected to increase from 81 717 in 2020 to 95 845 in 2035 (average annual growth rate: 1.2%). Although most cancer mortality rates were projected to decrease, those of breast, pancreatic, and ovarian cancer among female were projected to increase until 2035.

Conclusions: These up-to-date projections of cancer incidence and mortality in the Korean population may be a significant resource for implementing cancer-related regulations or developing cancer treatments.

Keywords: Epidemiology; Incidence; Mortality; Neoplasms.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have no conflicts of interest associated with the material presented in this paper.

Figures

Figure. 1.
Figure. 1.
Projected cancer incidence rates in Korean male and female from 2020 to 2035. (A) Common cancers (B) intermediate cancers and (C) rare cancers. NHL, non-Hodgkin lymphoma.
Figure. 2.
Figure. 2.
Projected cancer mortality rates in Korean male and female from 2020 to 2035. (A) Common cancers (B) intermediate cancers and (C) rare cancers. NHL, non-Hodgkin lymphoma.
See this image and copyright information in PMC

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
    1. World Health Organization Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000-2019. [cited 2020 Jul 24] Available from: https://www.who.int/data/stories/leading-causes-of-death-and-disability-....
    1. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat. 2019;51(2):417–430. - PMC - PubMed
    1. Jung YS, Kim YE, Park H, Oh IH, Jo MW, Ock M, et al. Measuring the burden of disease in Korea, 2008-2018. J Prev Med Public Health. 2021;54(5):293–300. - PMC - PubMed
    1. Jung KW, Won YJ, Hong S, Kong HJ, Lee ES. Prediction of cancer incidence and mortality in Korea, 2020. Cancer Res Treat. 2020;52(2):351–358. - PMC - PubMed